Published in Neuroimage Clin on June 03, 2016
Cognitive correlates of neuroimaging abnormalities in the onset of schizophrenia: A case report. World J Psychiatry (2017) 0.75
The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull (1987) 51.07
Unified segmentation. Neuroimage (2005) 30.20
A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging (1998) 23.54
A fast diffeomorphic image registration algorithm. Neuroimage (2007) 21.56
A review of MRI findings in schizophrenia. Schizophr Res (2001) 8.95
Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry (1987) 8.81
The Alzheimer's disease neuroimaging initiative. Neuroimaging Clin N Am (2005) 7.26
Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry (2000) 4.84
Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry (2009) 4.44
Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry (2005) 4.31
A systematic review of the effects of antipsychotic drugs on brain volume. Psychol Med (2010) 4.26
Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br J Psychiatry (2006) 3.66
Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry (2011) 3.53
Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings. Psychol Med (2009) 3.34
The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry (2008) 3.29
Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? Arch Gen Psychiatry (2002) 2.48
Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis. Br J Psychiatry (2009) 2.46
The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology (2005) 2.37
Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses. PLoS One (2012) 2.33
Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr Bull (2005) 2.13
Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized voxel-based morphometry and resting state functional connectivity study. Am J Psychiatry (2008) 1.86
Interpreting scan data acquired from multiple scanners: a study with Alzheimer's disease. Neuroimage (2007) 1.83
Neuroanatomical abnormalities in schizophrenia: a multimodal voxelwise meta-analysis and meta-regression analysis. Schizophr Res (2011) 1.81
Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biol Psychiatry (2011) 1.75
Is gray matter volume an intermediate phenotype for schizophrenia? A voxel-based morphometry study of patients with schizophrenia and their healthy siblings. Biol Psychiatry (2007) 1.73
Can voxel based morphometry, manual segmentation and automated segmentation equally detect hippocampal volume differences in acute depression? Neuroimage (2008) 1.72
Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies. Schizophr Bull (2011) 1.72
Finding the Elusive Psychiatric "Lesion" With 21st-Century Neuroanatomy: A Note of Caution. Am J Psychiatry (2015) 1.68
Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. Neurosci Biobehav Rev (2010) 1.66
Neuroimaging predictors of transition to psychosis--a systematic review and meta-analysis. Neurosci Biobehav Rev (2010) 1.65
Imaging artifacts at 3.0T. J Magn Reson Imaging (2006) 1.59
Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biol Psychiatry (2007) 1.57
Schizophrenia as a long-term outcome of pregnancy, delivery, and perinatal complications: a 28-year follow-up of the 1966 north Finland general population birth cohort. Am J Psychiatry (1998) 1.55
Comparing 3 T and 1.5 T MRI for tracking Alzheimer's disease progression with tensor-based morphometry. Hum Brain Mapp (2010) 1.55
Cavum septum pellucidum and adhesio interthalamica in schizophrenia: an MRI study. Eur Psychiatry (2006) 1.54
The role of the insula in schizophrenia. Schizophr Res (2010) 1.52
Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression. Schizophr Bull (2009) 1.51
Structural gray matter differences between first-episode schizophrenics and normal controls using voxel-based morphometry. Neuroimage (2002) 1.48
Voxel-based morphometric multisite collaborative study on schizophrenia. Schizophr Bull (2008) 1.43
Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. Neurosci Biobehav Rev (2013) 1.40
Superior temporal gyrus and the course of early schizophrenia: progressive, static, or reversible? J Psychiatr Res (1998) 1.39
Cerebral grey, white matter and csf in never-medicated, first-episode schizophrenia. Schizophr Res (2006) 1.36
Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology (1997) 1.34
The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia?--a systematic review. Curr Pharm Des (2009) 1.31
The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia. Schizophr Bull (2008) 1.30
Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies. Transl Psychiatry (2012) 1.29
Cumulative adversity and smaller gray matter volume in medial prefrontal, anterior cingulate, and insula regions. Biol Psychiatry (2012) 1.29
A large scale (N=400) investigation of gray matter differences in schizophrenia using optimized voxel-based morphometry. Schizophr Res (2008) 1.28
Adjusting for global effects in voxel-based morphometry: gray matter decline in normal aging. Neuroimage (2012) 1.27
Resting-state brain activity in schizophrenia and major depression: a quantitative meta-analysis. Schizophr Bull (2011) 1.26
A systematic review of the long-term outcome of early onset schizophrenia. BMC Psychiatry (2012) 1.25
The myth of schizophrenia as a progressive brain disease. Schizophr Bull (2012) 1.21
Changes in cortical thickness during the course of illness in schizophrenia. Arch Gen Psychiatry (2011) 1.21
Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys. Neuropsychopharmacology (2006) 1.20
Epidemiology of early-onset schizophrenia. Eur Arch Psychiatry Clin Neurosci (1995) 1.17
Multi-site voxel-based morphometry: methods and a feasibility demonstration with childhood absence epilepsy. Neuroimage (2008) 1.17
The relationship of structural alterations to cognitive deficits in schizophrenia: a voxel-based morphometry study. Biol Psychiatry (2005) 1.14
Heritability of multivariate gray matter measures in schizophrenia. Twin Res Hum Genet (2012) 1.14
Voxel-based morphometry of comorbid schizophrenia and learning disability: analyses in normalized and native spaces using parametric and nonparametric statistical methods. Neuroimage (2004) 1.14
Intracranial volume estimated with commonly used methods could introduce bias in studies including brain volume measurements. Neuroimage (2013) 1.14
Structural brain alterations at different stages of schizophrenia: a voxel-based morphometric study. Schizophr Res (2008) 1.13
Pitfalls in the use of voxel-based morphometry as a biomarker: examples from huntington disease. AJNR Am J Neuroradiol (2009) 1.10
Accurate automatic estimation of total intracranial volume: a nuisance variable with less nuisance. Neuroimage (2014) 1.09
Schizophrenia with auditory hallucinations: a voxel-based morphometry study. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.09
Reduced cortical folding in schizophrenia: an MRI morphometric study. Am J Psychiatry (2003) 1.08
Patterns of Gray Matter Abnormalities in Schizophrenia Based on an International Mega-analysis. Schizophr Bull (2014) 1.08
Validity of modulation and optimal settings for advanced voxel-based morphometry. Neuroimage (2013) 1.07
Limbic structures and networks in children and adolescents with schizophrenia. Schizophr Bull (2007) 1.07
Multicenter voxel-based morphometry mega-analysis of structural brain scans in obsessive-compulsive disorder. Am J Psychiatry (2014) 1.05
Regional impact of field strength on voxel-based morphometry results. Hum Brain Mapp (2010) 0.99
Regional gray matter volume deficits in adolescents with first-episode psychosis. J Am Acad Child Adolesc Psychiatry (2008) 0.98
Insight and regional brain volumes in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2007) 0.95
Grey matter abnormalities in Brazilians with first-episode psychosis. Br J Psychiatry Suppl (2007) 0.95
Is DARTEL-based voxel-based morphometry affected by width of smoothing kernel and group size? A study using simulated atrophy. J Magn Reson Imaging (2012) 0.92
The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies. Biol Psychiatry (2015) 0.91
Longitudinal volumetric MRI study in first- and multiple-episode male schizophrenia patients. Psychiatry Res (2005) 0.91
Schizophrenia as a progressive brain disease. Eur Psychiatry (2008) 0.90
Longitudinal changes in total brain volume in schizophrenia: relation to symptom severity, cognition and antipsychotic medication. PLoS One (2014) 0.89
No evidence for astrogliosis in brains of schizophrenic patients. A post-mortem study. Neuropathol Appl Neurobiol (1999) 0.89
Neuroanatomical correlates of psychosis in temporal lobe epilepsy: voxel-based morphometry study. Br J Psychiatry (2010) 0.89
Insular volume abnormalities associated with different transition probabilities to psychosis. Psychol Med (2011) 0.89
Incidence of first-contact psychosis in São Paulo, Brazil. Br J Psychiatry Suppl (2007) 0.88
Neurodevelopmental schizophrenia: the rediscovery of dementia praecox. Br J Psychiatry Suppl (1994) 0.87
Gray matter volume differences and the effects of smoking on gray matter in schizophrenia. Schizophr Res (2007) 0.87
Assessing age-related gray matter decline with voxel-based morphometry depends significantly on segmentation and normalization procedures. Front Aging Neurosci (2014) 0.87
Longitudinal progression of frontal and temporal lobe changes in schizophrenia. Schizophr Res (2012) 0.86
Structural brain changes associated with antipsychotic treatment in schizophrenia as revealed by voxel-based morphometric MRI: an activation likelihood estimation meta-analysis. BMC Psychiatry (2013) 0.86
First-episode studies in schizophrenia: criteria and characterization. Schizophr Bull (1992) 0.85
Reducing inter-subject anatomical variation: effect of normalization method on sensitivity of functional magnetic resonance imaging data analysis in auditory cortex and the superior temporal region. Neuroimage (2009) 0.85
Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-β activity. Genes Brain Behav (2010) 0.84
Abnormalities in structural covariance of cortical gyrification in schizophrenia. Brain Struct Funct (2014) 0.84
Influence of magnetic field strength and image registration strategy on voxel-based morphometry in a study of Alzheimer's disease. Hum Brain Mapp (2013) 0.83
Lack of progression of brain abnormalities in first-episode psychosis: a longitudinal magnetic resonance imaging study. Psychol Med (2010) 0.83
Workshop on defining the significance of progressive brain change in schizophrenia: December 12, 2008 American College of Neuropsychopharmacology (ACNP) all-day satellite, Scottsdale, Arizona. The rapporteurs' report. Schizophr Res (2009) 0.82
How reliable are gray matter disruptions in specific reading disability across multiple countries and languages? Insights from a large-scale voxel-based morphometry study. Hum Brain Mapp (2015) 0.77
Longitudinal regional brain volume loss in schizophrenia: Relationship to antipsychotic medication and change in social function. Schizophr Res (2015) 0.76
What determines continuing grey matter changes in first-episode schizophrenia and affective psychosis? Psychol Med (2014) 0.76
Insular Gray Matter Volume and Objective Quality of Life in Schizophrenia. PLoS One (2015) 0.75